Clinical trial

Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With…

NCT00005619 · Northwestern University, Other · Completed

Key facts

NCT number NCT00005619
Title Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia
Official title Detection of Hairy Cell Leukemia Minimal Residual Disease: Detection by Flow Cytometry
Lead sponsor Northwestern University, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Study type Observational
Conditions Leukemia
Intervention type Genetic, Other
Interventions polymerase chain reaction, flow cytometry, immunohistochemistry staining method
Enrollment 16
Start date Feb 1, 2000
Primary completion Aug 1, 2001
Completion Aug 1, 2001
First posted Jul 19, 2004
Last update posted Feb 21, 2011
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies